| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |